Verana Health introduces AI-powered research tools and massive patient datasets at AAO 2026, aiming to streamline clinical insights and data-driven decision-making for healthcare providers.
Verana Health's introduction of AI enhancements for ophthalmology research is a positive development for its healthcare data platform.
Verana Health debuted new AI-driven research agents and expanded datasets at the American Academy of Ophthalmology's annual meeting. The platform leverages de-identified data from over 90 million patients to accelerate clinical research and improve real-world evidence generation in ophthalmology.
The new AI Agents are designed to assist in research and data analysis, specifically leveraging large-scale, de-identified patient datasets to provide real-world insights for the ophthalmology sector.